DiaCarta Inc., a precision molecular diagnostic company, has announced the publication of its prospective clinical trial data on its blood-based test for triaging FIT (fecal immunochemical ...
The Global Helicobacter Pylori Diagnostics Market, valued at approximately USD 601.2 million in 2022, is projected to grow at a robust CAGR of more than 6% during the forecast period from 2023 to 2030 ...